Description

PRODUCT DESCRIPTION

• WHO Stage II opioid
• Active substance – meptazinol hydrochloride
• Indication – MEPTID® is indicated in moderate to severe pain of various causes.
• Composition – 1 ml of the solution for injection (1 ampoule) contains 115.6 mg meptazinol hydrochloride corresponding to 100 mg meptazinol.
• Posology – The dosage is determined by the physician. The usual dose is: Adult– i.v.: 50 mg to 100 mg meptazinol (= 0.5 ml to 1 ml MEPTID®) follow-up injection of the same dose every 2 to 4 hours if necessary.– i.m.: 75 to 100 mg meptazinol (= 0.75 ml to 1 ml MEPTID®) follow-up injection of the same dose every 2 to 4 hours if necessary. For pain relief in the first stage of birth 100 mg to 150 mg meptazinol (= 1 ml to 1.5 ml MEPTID®), up to 2 mg meptazinol per kg body weight, depending on the patient’s weight. Children: There is no experience with children.